Category: News
Groundbreaking Phase I clinical trial results: (2R,6R)-Hydroxynorketamine (HNK) shows excellent safety profile.
No Comments
| News
We are thrilled to announce a major milestone in our research journey. The manuscript detailing the Phase I clinical trial results for (2R,6R)-Hydroxynorketamine (HNK), a metabolite of ketamine, has just been published. The study, titled “A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-HNK in healthy volunteers,” demonstrates the compound’s excellent […]
Dr. Zanos’s Research Leads the Field in Ketamine Studies for Depression
We are proud to announce that Dr. Zanos’s groundbreaking research on ketamine has achieved exceptional recognition within the scientific community. According to a recent publication in the European Archives of Psychiatry and Clinical Neuroscience, Dr. Zanos’s work constitutes the top three most cited papers on ketamine and its enantiomers for depression from 2000 to 2023. […]
Gut-Brain connections: Dr. Charalambous presents groundbreaking research on phageome and brain ageing at Grainau workshop
Our postdoctoral researcher Eleftheria Charalambous presented our latest findings at the 12th Grainau Workshop of Genetic Epidemiology in Grainau, Germany. With her talk “The gut phageome is associated with brain ageing” she sparked insightful conversations with other researchers. Dr. Charalambous studies the link between bacteriophages in the gut microbiome and the brain. Bacteriophages are viruses […]
Dr. Zanos was invited as an expert to give an interview and answer critical question about depression and its underlying mechanisms by a groundbreaking European-funded initiative.
Dr. Zanos was invited as an expert contributor to the “TO AITION” project’s Q&A section. “TO AITION” is a groundbreaking EU-funded project investigating the complex relationship between cardiovascular disease (CVD) and depression, aiming to uncover underlying mechanisms and develop novel tools for prevention, diagnosis, and treatment. In this role, Dr. Zanos addressed critical questions about […]
Dr. Zanos discusses drug addiction on the satellite television channel of the Cyprus Broadcasting Corporation (RIK 1).
We are thrilled to share that Dr. Panos Zanos was invited to appear on RIK Sat, the satellite television channel of the Cyprus Broadcasting Corporation (CyBC), to discuss the critical issue of drug addiction. This invitation from RIK Sat, one of Cyprus’s premier broadcasting platforms, underscores the significance of Dr. Zanos’ work in the field […]
New Preprint: Network-Based Analysis Identifies Targetable Pathways in Comorbid Type II Diabetes and Neuropsychiatric Disorders.
We are pleased to announce the release of a new preprint from Dr. Anna Onisiforou and Dr. Panos Zanos, titled “Network-Based Analysis Identifies Targetable Pathways in Comorbid Type II Diabetes and Neuropsychiatric Disorders.” This preprint is available on bioRxiv and represents a significant step forward in understanding the complex interactions between Type 2 Diabetes Mellitus […]
Dr. Zanos Speaks on Neurobiology of Drug Addiction at Substance Use Disorders Awareness Event in Cyprus
We are excited to share that Dr. Zanos was invited by OFSEAK Cyprus and the Cyprus Anti-Cancer Society to deliver a keynote address on the neurobiology of drug addiction at a recent Substance Use Disorders Awareness event. This notable event took place in Cyprus and was covered extensively by several television outlets. Dr. Zanos’s presentation […]
New Publication: Molecular Signatures of Premature Aging in Major Depression and Substance Use Disorders.
We are excited to announce the latest publication from our talented Research Associate and Head of the Bioinformatics Unit, Dr. Anna Onisiforou, in collaboration with Dr. Polymnia Georgiou. Their groundbreaking paper, titled “Molecular signatures of premature aging in Major Depression and Substance Use Disorders,” has been published in Scientific Data (Nature Group). Major depressive disorder (MDD) and […]
Our postdoctoral researcher, Dr. Eleftheria Charalambous, presented our latest findings at the 10th International Human Microbiome Consortium (IHMC) Congress 2024
Her presentation, titled “The gut phageome is associated with healthy brain ageing” drew significant interest from fellow researchers. Dr. Charalambous’s work explores the connection between bacteriophages in the gut microbiome and cognitive health as we age. Her research suggests that the makeup and variety of the gut phageome may play an important role in maintaining […]
Dr. Zanos discusses the path to alcohol dependence on a TV program (watch @57:40 min).
Dr. Zanos was recently invited to speak on a TV channel about the neurobiology of alcohol addiction, where he explored the complex processes that lead from casual alcohol use to full-blown dependence. Initially, alcohol consumption often presents an aversive taste; however, this negative experience is quickly overshadowed by the activation of the brain’s reward system. […]